Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:15 PM
Ignite Modification Date:
2026-03-26 @ 3:15 PM
NCT ID:
NCT07370792
Eligibility Criteria:
Inclusion Criteria
* Patients presenting with at least two congenital anomalies, with or without intellectual disability, and weighing more than 5 kg.
* Whole-genome sequencing performed by the AURAGEN laboratory deemed non-contributive (absence of class 4 or 5 variants, or identification of a VUS, or identification of only one variant in the context of a recessive disorder).
* Patient covered by a social security scheme.
* Patient able to understand and to oppose participation in the study.
* Written informed consent for genetic analyses, signed either by the patient or by their legal representatives (for minors), after clear and fair information about the study has been provided.
Non-Inclusion Criteria
* Patients for whom a non-genetic cause (infectious, environmental, or toxic) has been previously identified.
* Inability to obtain a compliant sample.
* Patient or holder of parental authority under guardianship or legal protection, deprived of liberty, or placed under court-ordered protection.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT07370792
Study Brief:
Protocol Section:
NCT07370792